Simplex Trading, LLC Beyond Spring Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$0.85 - $3.63 $1,149 - $4,907	1,352 New	1,352 $4,000
Q4 2022 Feb 02, 2023	BUY	$0.56 - $2.61 $8,953 - $41,728	15,988 New	15,988 $30,000
Q2 2022 Aug 03, 2022	SELL	$1.13 - $2.66 $18,859 - $44,395	-16,690 Reduced 97.22%	478 $0
Q1 2022 May 02, 2022	SELL	$1.68 - $5.01 $116,617 - $347,769	-69,415 Reduced 80.17%	17,168 $37,000
Q4 2021 Feb 23, 2022	BUY	$4.02 - $16.84 $323,429 - $1.35 Million	80,455 Added 1312.91%	86,583 $392,000
Q3 2021 Oct 28, 2021	SELL	$9.26 - $31.31 $9,741 - $32,938	-1,052 Reduced 14.65%	6,128 $65,000
Q2 2021 Aug 12, 2021	BUY	$9.37 - $12.12 $64,025 - $82,815	6,833 Added 1969.16%	7,180 $74,000
Q1 2021 Apr 26, 2021	BUY	$10.61 - $15.77 $3,681 - $5,472	347 New	347 $3,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $68.1M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.